Mankind Pharma Ltd.'s market cap is currently ₹1.02T. The company's EPS TTM is ₹10.7; its P/E ratio is 53.21; and it has a dividend yield of 0.04%. Mankind Pharma Ltd. is scheduled to report earnings on July 31, 2025, and the estimated EPS forecast is ₹13.00. See an overview of income statement, balance sheet, and cash flow financials.
